Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic: Summary & Key Insights

The COVID‑19 story begins, not in Seattle or New York, but in Wuhan. Through December 2019 and January 2020, intelligence and health agencies around the world received early reports that a novel coronavirus was spreading in China. The U.S. had both the means and the knowledge to interpret those signals. We had the intelligence community’s global reach and the CDC’s epidemiological expertise. And yet, our early detection mechanisms were paralyzed—not because people didn’t care, but because our institutions were simply not designed for speed or uncertainty.

In the initial weeks, I watched with growing frustration as evidence accumulated but no coherent response emerged. Travel screening systems failed to catch asymptomatic carriers. Customs declarations were meaningless. Public health authorities clung to the idea that containment was still feasible, even as the virus silently seeded major American cities. The bureaucratic culture of the CDC favored thorough deliberation over rapid adaptation. It’s a valuable trait in normal times—but disastrous when each day counts.

Meanwhile, political leaders hesitated, in part because early intelligence was ambiguous and filtered through procedural channels that delayed decisive action. In *Uncontrolled Spread*, I recount how classified briefings and interagency communications reflected a hope that the crisis would remain regional. But pandemics don’t wait for paperwork. By the time leaders recognized COVID‑19’s true transmissibility, containment was already impossible.

This missed opportunity underscores a larger point: we lacked a national capacity for rapid threat assessment. Unlike defense agencies accustomed to acting under uncertainty, public health institutions demanded near-perfect evidence before escalating responses. That epistemic rigidity cost lives. The lesson is clear—next time, we must empower structures that can act on imperfect information, recalibrating as data improves, rather than waiting for bureaucratic consensus.

One of the most painful discoveries during COVID‑19 was that the U.S. did not have one public health system—it had hundreds, loosely connected and often working at cross purposes. The CDC, the FDA, the Department of Health and Human Services, and state health departments each operated under independent mandates. This fragmentation created deadly friction.

As I describe in the book, the CDC’s historic mission was never to manage national emergencies—it was to conduct research, surveillance, and guidance. That model made sense in calmer times. But in a pandemic, its authority evaporated into confusion. The FDA, on the other hand, was responsible for regulating diagnostics and therapeutics, yet its processes were optimized for safety reviews over months, not emergency decisions over days. When the two agencies tried to coordinate, their mutual caution froze innovation.

Our early testing crisis exemplified this dysfunction. The CDC created the first federal diagnostic kits, but the kits were contaminated due to a manufacturing oversight. Instead of immediately enlisting private labs to design alternatives, the bureaucracy doubled down on internal processes. Weeks passed as infections spread unchecked. The root problem wasn’t bad people—it was a system built for incremental management, not wartime mobilization.

Through these events, I argue that pandemic preparedness must be redefined as a national security function. In military crises, we wouldn’t allow multiple uncoordinated chains of command. Yet that’s exactly what we did in health emergencies. To be prepared, we need a central authority capable of interlinking all agencies, ensuring unity of mission and accountability of action.